权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Utilizing Dendritic Cell Biology to Characterize the Innate Immune Response to Blood Coagulation Proteins

利用树突状细胞生物学来表征对凝血蛋白的先天免疫反应

基本信息

批准号：
10456679
负责人：
Glaivy Batsuli
金额：
$ 20.25万
依托单位：
EMORY UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
起止时间：
2020-03-01 至 2025-02-28
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10456679
关键词：
Address Affect Allergic Anaphylaxis Antibodies Antibody Formation Antibody Response Antigen Presentation Antigen Presentation Pathway Antigen-Antibody Complex Antigen-Presenting Cells Antigens B-Cell Activation B-Lymphocytes Blood Blood Coagulation Disorders Blood coagulation C Type Lectin Receptors CD4 Positive T Lymphocytes CD8B1 gene Cell Communication Cell physiology Cells Cellular biology Complement Activation Complex Confocal Microscopy Dendritic Cells Dendritic cell activation Deposition Development Development Plans Disease Endocytosis Ensure Event Exogenous Factors F8 gene Factor IX Factor VIII Flow Cytometry Glycoproteins Hemophilia A Hemophilia B Hemorrhage ITAM ITGAX gene ITIM Immediate hypersensitivity Immune Tolerance Immune response Immunity Immunize Immunologics Immunology In Vitro Incidence Individual Inflammation Infusion procedures Inherited Innate Immune Response Intraperitoneal Injections Intravenous Intravenous infusion procedures Laboratories Lecithin Lipopolysaccharides Lysosomes MHC Class II Genes Measures Mediating Microspheres Molecular Biology Mus Natural Immunity Nephrotic Syndrome Ovalbumin Patients Phagocytes Phagocytosis Pharmacology Play Poly I-C Polystyrenes Process Property Proteins Research Risk Role Sampling Signal Transduction Spleen Subcutaneous Injections T cell response T-Cell Activation T-Cell Proliferation T-Lymphocyte Techniques Testing Training Translational Research Work XCR1 gene adaptive immune response career career development cohort immunogenicity inhibitor intravenous injection late endosome macrophage mouse dectin-2 mouse model neutralizing antibody prevent receptor receptor mediated endocytosis response uptake

项目摘要

Project Summary Inherited deficiencies of blood coagulation glycoproteins factor VIII (FVIII) or factor IX (FIX) result in the bleeding disorders hemophilia A and B, respectively. These individuals require intravenous infusions of exogenous factor to treat and prevent bleeding events. However 30% of patients with severe hemophilia A and 1-3% of patients with hemophilia B will form neutralizing antibodies called inhibitors against FVIII and FIX respectively. Although the immune response to FVIII and FIX are both dependent on CD4+ T cell responses, inhibitors to FIX can induce allergic IgE-mediated hypersensitivity responses and nephrotic syndrome due to immune complex deposition, which are rarely seen in patients with FVIII inhibitors. Antigen presenting cells (APCs), including dendritic cells (DCs), B cells, and macrophages, are essential for sensing antigens and directing adaptive immune responses towards immunity or tolerance. DCs have an enhanced ability to capture and process antigens for presentation on MHC complexes to naïve T cells. There is limited understanding of the underlying mechanisms and critical cellular components that mediate innate immunity to FVIII and FIX. The main objective of this work is to characterize the role of DCs in the innate immune response to FVIII and FIX. This proposal consists of 3 specific aims: 1) Evaluate the role of conventional DCs in CD4+ T cell dependent- antibody formation in murine models of hemophilia A and B, 2) Identify the mechanisms of FVIII and FIX recognition and internalization by conventional DCs, and 3) Determine the properties of FVIII and FIX that mediate DC activation and co-stimulatory signaling. In Aim 1, T cell responses and antibody formation will be measured after targeted depletion of APC subsets in mice immunized with FVIII, FIX, or ovalbumin. The role of phagocytosis, macropinocytosis, and receptor-mediated endocytosis through C-type lectin receptors DCIR2 and Dectin-2 in FVIII and FIX uptake under normal conditions and with inflammation will be evaluated to determine the mechanism of factor recognition and internalization by DCs in Aim 2. In Aim 3, the effect of increasing concentrations of FVIII and FIX on DC activation in vitro will be measured. Additionally, the effect of inhibiting DC co-stimulatory signals on T cell activation, antibody responses, and complement activation in hemophilia A and B mice immunized by intravenous, subcutaneous, or intraperitoneal injections of FVIII and FIX will be evaluated. A fundamental understanding of these mechanisms will be important for evaluating immunologic changes in hemophilia patients during early factor exposure and for the development of strategies that prevent and eradicate inhibitors. The career development plan outlined will address training in immunology, molecular biology laboratory techniques, and translational research to ensure successful transition to research independence.

项目总结